PANICCIA, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.303
EU - Europa 9.558
AS - Asia 3.649
SA - Sud America 499
AF - Africa 128
Continente sconosciuto - Info sul continente non disponibili 128
OC - Oceania 96
Totale 24.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.129
PL - Polonia 3.712
RU - Federazione Russa 2.062
IT - Italia 1.547
SG - Singapore 1.077
CN - Cina 758
HK - Hong Kong 592
IE - Irlanda 533
SE - Svezia 497
VN - Vietnam 445
BR - Brasile 391
DE - Germania 316
KR - Corea 299
UA - Ucraina 238
FI - Finlandia 203
GB - Regno Unito 174
FR - Francia 163
CA - Canada 111
IN - India 107
AU - Australia 92
BD - Bangladesh 55
JP - Giappone 47
TR - Turchia 42
ID - Indonesia 41
JO - Giordania 41
AR - Argentina 38
IQ - Iraq 28
NL - Olanda 28
CI - Costa d'Avorio 26
MX - Messico 22
EC - Ecuador 20
ES - Italia 20
PK - Pakistan 18
ZA - Sudafrica 18
BE - Belgio 15
NG - Nigeria 15
MA - Marocco 14
VE - Venezuela 14
SA - Arabia Saudita 13
CO - Colombia 12
TN - Tunisia 12
CR - Costa Rica 9
OM - Oman 9
DK - Danimarca 8
EG - Egitto 8
KE - Kenya 8
PH - Filippine 8
TH - Thailandia 8
TW - Taiwan 8
CL - Cile 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
MY - Malesia 7
PE - Perù 7
SC - Seychelles 7
UZ - Uzbekistan 7
BJ - Benin 6
KZ - Kazakistan 6
LT - Lituania 6
BG - Bulgaria 5
CH - Svizzera 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AZ - Azerbaigian 4
CU - Cuba 4
DO - Repubblica Dominicana 4
HN - Honduras 4
LB - Libano 4
LV - Lettonia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IR - Iran 3
MN - Mongolia 3
SN - Senegal 3
SV - El Salvador 3
AL - Albania 2
BS - Bahamas 2
GE - Georgia 2
MU - Mauritius 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
Totale 24.225
Salva come PNG Salva come JPEG
Città #
Warsaw 3.706
Santa Clara 2.101
Ashburn 1.027
Fairfield 912
Singapore 775
Chandler 556
Dublin 531
Hong Kong 473
Woodbridge 388
Jacksonville 371
Seattle 365
Houston 322
Cambridge 317
San Jose 317
Wilmington 296
Seoul 287
Milan 284
Council Bluffs 208
Florence 208
Beijing 193
Ann Arbor 173
Princeton 146
Ho Chi Minh City 135
Rome 135
Buffalo 128
Lawrence 123
Altamura 122
The Dalles 119
Lauterbourg 111
Hanoi 98
Boardman 97
Los Angeles 96
Medford 93
Melbourne 84
New York 81
Moscow 75
Hefei 74
Boston 71
Mumbai 71
Helsinki 64
San Diego 61
Phoenix 57
Shanghai 55
Munich 52
Dallas 49
Dong Ket 44
London 42
São Paulo 38
Tokyo 38
Naples 36
Figino 34
Jakarta 33
Bologna 31
Columbus 30
Norwalk 27
Abidjan 26
Turin 26
Toronto 24
Izmir 22
Chicago 21
Kent 21
Redondo Beach 20
Springfield 18
Da Nang 17
Andover 16
Brescia 16
Orem 16
Palermo 16
Washington 16
Haiphong 15
Paris 15
Brussels 14
Clifton 14
Falls Church 14
Latina 14
Montreal 14
Auburn Hills 13
Bari 13
Brooklyn 13
Tianjin 13
Guangzhou 12
Hillsboro 12
Miano 12
Turku 12
Verona 12
Frankfurt am Main 11
Padua 11
Rio de Janeiro 11
San Francisco 11
Barcelona 10
Belo Horizonte 10
Frankfurt Am Main 10
Utrecht 10
Yubileyny 10
Abuja 9
Atlanta 9
Baghdad 9
Genoa 9
Amman 8
Cagliari 8
Totale 16.993
Salva come PNG Salva come JPEG
Nome #
Assessment of platelet function: Laboratory and point-of-care methods 383
Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist. 380
Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure 373
High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers. 368
Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics 367
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 366
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress 364
High platelet turnover and reactivity in renal transplant recipients patients 357
Platelet Function tests: A Comparative Review 350
Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes. 349
Effect of blood hematocrit and erythrocyte deformability on adenosine 5' -diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy 326
Index measured at an intermediate altitude to predict impending acute mountain sickness 326
Increased renal formation of thromboxane A 2 and prostaglandin F 2α in heart failure 319
Selective Upregulation of Cardiac Endothelin System in Patients With Ischemic but Not Idiopathic Dilated Cardiomyopathy. Endothelin-1 System in the Human Failing Heart 316
Bioequivalence in the real world is a complex challenge: the case of clopidogrel 316
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis 314
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome 313
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarction 309
Aumentata produzione di trombossano A2 e di PGE2 con normale conversione di 1-14 C acido arachidonico da parte delle piastrine nei soggetti diabetici. 306
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 294
Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy 291
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. 289
The balance between pro- and anti-infilammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients 288
Perioperative assessment of platelet function by Thromboelastograph Platelet MappingTM in cardiovascular patients undergoing non-cardiac surgery 285
Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment 281
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention 281
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. 269
Hign on treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting 248
Point-of-care testing of hemostasis in cardiac surgery 234
ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment 217
A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy. 207
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 204
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis 203
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes 203
Platelet Reactivity in Hepatitis C Virus-Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome 202
S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: Preliminary observation of a 6-month follow-up study 194
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 194
Age related changes in platelet lipid composition 191
Fibrin generation and digestion in patients with angina pectoris 183
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12 month follow-up 182
Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes 180
No signs of increased thrombin generation in menopause 178
Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophilis: in vitro effect of dipyrone 178
Relationship between classical FDP test and D-dimer assayed both by latex agglutination and ELISA 177
Evaluation of clotting and fibrinolytic activation after protracted physical exercise 176
Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease. 174
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty 173
Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients 173
Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps 173
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents 170
Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy 168
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. 168
Anticoagulant effect of dabigatran, rivaroxaban or apixaban treatment on different laboratory hemostasis tests in patients with atrial fibrillation 168
Time-sequence activation and relationship with cardiac functon of angiotensinogen, endothelin-1 and insulin-like growth factor-I gene expression in acutely overloaded pigs 166
Acitivty of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study 165
Red blood cell lipid alterations in type II diabetes mellitus. 164
Age-related changes in red blood cell lipids 164
Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. 164
Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion 164
Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia 163
Exercise-induced tissue plasminogen activator increase: a role for metabolic acidosis. 163
Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study 162
Endothelin receptors in adult human and swine isolated ventricular cardiomyocytes. 160
Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. 159
Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx 158
Effect of temperature and incubation time on D-dimer serum levels in healthy subjects. 157
Lipid, inflammatory, and haemorheological profiles are significantly affected by farmed fish eating: an intervention study 155
Haemostasis and Cytokines Modifications in Elite Cyclists 155
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 154
Monitoring platelet function in coronary heart disease patients on clopidogrel therapy: whole blood multiplate impedance aggregometer compared to classical and new platelet function methods 154
Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. 154
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study. 153
Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy 151
Influence of dabigatran, rivaroxaban or apixaban treatment on hemostasis point-of-care testing (POCT) in patients with atrial fibrillation. 151
D-dimer plasma levels in pathological pregnancy: use of a rapid test (NycoCard). 149
Post-PCI thrombin generation and cardiovascular mortality in acute coronary syndrome patients 149
THROMBOELASTOMETRIC ASSAY FOR MONITORING HEMOSTASIS DURING EXTRACORPOREAL MEMBRANE OXYGENATION IN ACUTE RESPIRATORY DISTRESS SYNDROME PATIENTS 146
Platelet activation and platelet lipid composition in pulmonary cancer 146
Accuracy of a Point-of-Care system for PT/INR test performed in the hospital anticoagulation clinic 146
Prostaglandins (PG) and Cervical Metastases in laringea cancer 146
Nasal polyps in allergic and non-allergic rhinitis: role of arachidonic acid metabolites 145
Impaired Ang II mediated activation of ERK1/ERK2 and SAPK/JNK pathways with normal AT1 receptor binding and mRNA expression in myocytes from failing human hearts 145
Euglobulin lysis time in fresh and storedi samples 144
Altered lipid composition and thromboxane A2 formation in platelets from patients affected by II Hyperlipoproteinemia. 144
Relationship between plasma and platelet phospholipid fatty acid composition in healthy subjects 141
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. 140
Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome 140
Low-dose heparin as an antithrombotic agent 139
Influence of dietary fish intake on inflammatory and rheological parameters: an intervention study 137
Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy. 135
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients 135
PGI2 PLATELET RECEPTORS ARE AFFECTED BY CHOLESTEROL PHOSPHOLIPID MOLAR RATIO 135
Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients. 135
Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients 134
Thrombin generation after physical exercise 133
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register 132
Sex related differences in platelet TxA2 generation 131
Usefulness of lyophilized calibration plasmas for International Normalized Ratio determination with the bovine combined thromboplastin (Thrombotest): results of a collaborative study. 131
Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes 130
Patient blood management in cardiac surgery: The "Granducato algorithm". 129
Totale 20.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022811 0 0 59 48 43 37 43 60 47 41 171 262
2022/20232.295 238 390 113 146 206 414 315 138 241 13 54 27
2023/2024884 19 107 146 43 68 152 16 157 19 43 58 56
2024/20255.521 173 539 439 829 1.592 933 57 271 272 138 136 142
2025/20265.828 599 754 326 306 673 257 705 390 365 353 148 952
2026/2027652 195 218 239 0 0 0 0 0 0 0 0 0
Totale 24.361